RESEARCH
[Publication] Mammalian Tolerance to Amino Acid Heterochirality
July 22, 2025
Organisms preferentially use l-amino acids (l-AAs). However, de novo synthesized l-AAs are in part converted to d-AAs. The ribosome has a robust system to use l-AAs for protein synthesis, whereas non-ribosomal synthesis can also use d-AAs. Furthermor
Credits: 2025 Sakiko Taniguchi et al.
Co-authored by Bio2Q and Keio University researchers, this Review explores the role of D-amino acids in mammals, highlighting their functional relevance despite the body’s predominant use of L-enantiomers. The authors outline how enzymatic control, microbial interactions, and tissue-level adaptations allow mammals to maintain control over environments with mixed amino acid chirality.
| Title | Mammalian Tolerance to Amino Acid Heterochirality |
|---|---|
| Authors | Sakiko Taniguchi [1],[2], Kenichiro Adachi [1], Xuan Tran [1],[3], Masataka Suzuki [1],[4], Jumpei Sasabe [5],[6], |
| Short Description | This review article, co-authored by Bio2Q and Keio University researchers, examines how mammals tolerate and utilize D-amino acids, once thought to be inert or even harmful byproducts of metabolism. While systemic amino acid metabolism strongly favors L-enantiomers, this work highlights the active roles that D-amino acids play in the brain, endocrine system, immune signaling, and in the gut epithelium. The authors integrate findings from across disciplines, including microbiome science, to explore how enzymatic degradation, renal filtration, and cellular proofreading mechanisms coordinate to maintain overall homochirality, while also supporting functional heterochirality. This Review works to reframe D-amino acids not as metabolic errors, but as selectively integrated components of mammalian physiology, offering a foundation for future research into their regulatory and therapeutic potential. |
| DOI | https://doi.org/10.1016/j.coi.2025.102568. |
| Journal | ChemBioChem |
| Vol/Num/Page | Volume 26, Issue 13, e202500273 |
| Publication Date | 2025 June 3. |
Affiliations:
[1] Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
[2] Research Fellow of Japan Society for the Promotion of Science, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
[3] Department of Plant Physiology, Eberhard Karls Universitat Tubingen, Auf der Morgenstalle 32, 72076 Tubingen, Germany
[4] Department of Medicine, Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115 USA
[5] Laboratory of Electron Microscope and Chiral Medical Biology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
[6] WPI-Bio2Q, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
SHARE
More Bio2Q News
【Publication】Lysophosphatidic acid drives to mirror-image pain via corpus callos...
Co-authored by Bio2Q researchers and published in Communications Biology, this study clarifies how lysophosphatidic acid (LPA) propagates in...
【Publication】Parallelizable search-space decomposition for large-scale combinato...
Co-authored by Bio2Q researchers (Scientific Reports), this study significantly accelerates large-scale optimization by splitting problems f...
Bio2Q to Participate and Exhibit at the 15th WPI Science Symposium
The 15th WPI Science Symposium will be held on Saturday, November 14, 2026, at the Osaka University Suita Campus Convention Center. This ...
【Publication】Mitochondria-targeting ACSL6 variant drives mitochondrial fragmenta...
Co-authored by researchers from Bio2Q and published in Scientific Reports, this study reveals how a short ACSL6 enzyme variant selectively t...
【Publication】bifidoAnnotator: fine-grained annotation of bifidobacterial glycosi...
Co-authored by Bio2Q researchers and published in Microbial Genomics, this study presents "bifidoAnnotator," a tool designed for the highly ...
